Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Combining EVP roles of Human Health Biosolutions and Strategy & Integration
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
ASML reports transactions under its current share buyback program
-
BIO-key and Cloud Distribution Co. Partner to Expand IAM and Biometric Security Solutions Across the Middle East
-
Porsche Cars North America’s Ayesha Coker recognized among 100 leading women in the North American auto industry
-
Transactions under Novonesis’ share buyback program
-
Agenda
-
TopBuild Extends and Upsizes Senior Secured Credit Facilities
-
IES Holdings, Inc. Appoints Matthew Simmes to Succeed Jeffrey Gendell as Chief Executive Officer
-
AMD Announces Agreement to Divest ZT Systems Data Center Infrastructure Manufacturing Business to Sanmina
-
Renowned IO Economist Professor B. Douglas Bernheim Affiliates with Compass Lexecon
-
Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD)
-
Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to
-
Reunion Neuroscience Announces Last Patient Dosed in RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
-
Atsena Therapeutics Announces Positive Clinical Data from Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy to Treat X-linked Retinoschisis (XLRS)
-
Director/PDMR Shareholding
-
Auction result of Treasury Bills - RIKV 25 0820 - RIKV 25 1119
-
Form 8.3 - Primary Health Properties
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RENEWI PLC - Ordinary Shares
-
Gilat Reports First Quarter 2025 Results
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BAKKAVOR GROUP PLC - Ordinary Shares
-
Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System
-
FEMSA Announces Accelerated Share Repurchase Agreement
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AVIVA PLC - Ordinary Shares
-
LIS Technologies Inc. to Unleash American Energy: Closing of Third Consecutive Oversubscribed Funding Round of $11.93M and Totaling Over $47M to Rebirth the Only United States Origin and Patented Tech
-
Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness
-
Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
-
Medical Learning Institute Inc Launches reelCE™, a Social-First Approach to Earning Continuing Education Credit
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ASSURA PLC - Ordinary Shares
-
Mobilicom Provides First Quarter 2025 Update and Financial Highlights
-
XORTX Announces USD $3 Million Offering
-
Infinium will deploy Electric Hydrogen’s electrolyzer plant at large-scale eFuels facility in Texas
-
Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference
-
H&E Rentals Provides Update on Quarterly Cash Dividend
-
Recommended A$0.08 Per Share Cash Offer
-
OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit
-
Tecnoglass to Attend the B. Riley Securities 25th Annual Institutional Investor Conference
-
Mobilicom Provides First Quarter 2025 Update and Financial Highlights
-
LanzaTech Announces First Quarter 2025 Financial Results
-
Chuck E. Cheese Recognized as a 2024–2025 “Best in STEM” Brand
-
Mesa Air Group Reports First Quarter Fiscal 2025 Results
-
Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference
-
Iterum Therapeutics Announces Extension of Term of Promissory Note
-
Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes
-
Signify share repurchase period update
-
Form 8.3 - [Alpha Group International plc]
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
Festi hf.: Share option plan for employees of the Festi Group
-
Pharvaris to Present Deucrictibant Clinical Data and Exploratory Biomarker Data at Upcoming Congresses
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities

